Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse. (Q48337319)
Jump to navigation
Jump to search
scientific article published on 14 December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse. |
scientific article published on 14 December 2006 |
Statements
1 reference
Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse. (English)
1 reference
István Gyertyán
1 reference
Béla Kiss
1 reference
Krisztina Gál
1 reference
István Laszlovszky
1 reference
Attila Horváth
1 reference
Larisza I Gémesi
1 reference
Katalin Sághy
1 reference
Gabriella Pásztor
1 reference
Mária Zájer
1 reference
Margit Kapás
1 reference
Eva Agai Csongor
1 reference
György Domány
1 reference
Károly Tihanyi
1 reference
Zsolt Szombathelyi
1 reference
14 December 2006
1 reference
320
1 reference
1268-1278
1 reference
3
1 reference
Identifiers
1 reference
1 reference